D&D Pharmatech
Seongnam · Founded 2014
About D&D Pharmatech
D&D Pharmatech is a operator of a holding company created to fund the development of therapeutic medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. The company's product pipeline focuses on a range of indications including neurodegenerative, metabolic and fibrotic diseases, providing the opportunity to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $224.1M
- Funding stage: IPO
- Last round: Series C (Oct 2021)
- Ticker: kosdaq:347850
- Website: ddpharmatech.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/d-d-pharmatech-10626 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.